151 related articles for article (PubMed ID: 11932216)
1. The influence of applicator angle on dosimetry in vaginal vault brachytherapy.
Hoskin PJ; Bownes P; Summers A
Br J Radiol; 2002 Mar; 75(891):234-7. PubMed ID: 11932216
[TBL] [Abstract][Full Text] [Related]
2. Vaginal vault brachytherapy: the effect of varying bladder volumes on normal tissue dosimetry.
Hoskin PJ; Vidler K
Br J Radiol; 2000 Aug; 73(872):864-6. PubMed ID: 11026862
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant brachytherapy for endometrial cancer: advantages of the vaginal mold technique.
El Khoury C; Dumas I; Tailleur A; Morice P; Haie-Meder C
Brachytherapy; 2015; 14(1):51-5. PubMed ID: 25183208
[TBL] [Abstract][Full Text] [Related]
4. Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer.
Caon J; Holloway C; Dubash R; Yuen C; Aquino-Parsons C
Brachytherapy; 2014; 13(1):94-9. PubMed ID: 24269147
[TBL] [Abstract][Full Text] [Related]
5. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
7. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?
Zhou J; Prisciandaro J; Lee C; Schipper M; Eisbruch A; Jolly S
Pract Radiat Oncol; 2014; 4(1):20-6. PubMed ID: 24621419
[TBL] [Abstract][Full Text] [Related]
8. The impact of rectal/bladder filling and applicator positioning on in vivo rectal dosimetry in vaginal cuff brachytherapy using an enhanced therapy setting.
Bergau PFL; Schirmer MA; Leha A; Leu M; Emons G; Hess CF; Hille A
Brachytherapy; 2020; 19(2):168-175. PubMed ID: 31883803
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2D and 3D imaging and treatment planning for postoperative vaginal apex high-dose rate brachytherapy for endometrial cancer.
Russo JK; Armeson KE; Richardson S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e75-80. PubMed ID: 22330985
[TBL] [Abstract][Full Text] [Related]
10. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional treatment planning for vaginal cuff brachytherapy: dosimetric effects on organs at risk according to patients position.
Iatì G; Pontoriero A; Mondello S; Brogna A; Di Pasquale A; Ielo I; Potami A; Messina G; De Renzis C; Pergolizzi S
Brachytherapy; 2014; 13(6):568-71. PubMed ID: 24986362
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
[TBL] [Abstract][Full Text] [Related]
13. Bladder and rectum dose estimations on digitized radiographs for vaginal brachytherapy after hysterectomy.
Zhang W; Bhatia SK; Sun W; Modrick JM; Kim Y
J Appl Clin Med Phys; 2014 Nov; 15(6):5033. PubMed ID: 25493529
[TBL] [Abstract][Full Text] [Related]
14. Individual fraction optimization vs. first fraction optimization for multichannel applicator vaginal cuff high-dose-rate brachytherapy.
Symon Z; Menhel J; Alezra D; Pfeffer MR
Brachytherapy; 2006; 5(4):211-5. PubMed ID: 17118311
[TBL] [Abstract][Full Text] [Related]
15. Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma.
Rovirosa Á; Herreros A; Camacho C; Ascaso C; Sánchez J; Cortés S; Sabater S; Solà J; Torné A; Arenas M
Brachytherapy; 2017; 16(6):1169-1174. PubMed ID: 28801116
[TBL] [Abstract][Full Text] [Related]
16. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
[TBL] [Abstract][Full Text] [Related]
17. A new method of anatomically conformal vaginal cuff HDR brachytherapy.
Miller DA; Richardson S; Grigsby PW
Gynecol Oncol; 2010 Mar; 116(3):413-8. PubMed ID: 19892389
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
19. The dosimetric impact of air in vaginal vault brachytherapy.
Maxwell Á; Thiruthaneeswaran N; Lowe G; Wills R; Sripali S; Hoskin PJ
Brachytherapy; 2016; 15(6):832-838. PubMed ID: 27693171
[TBL] [Abstract][Full Text] [Related]
20. Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma.
Rai B; Patel FD; Chakraborty S; Sharma SC; Kapoor R; Aprem AS
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e217-22. PubMed ID: 23517809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
